South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018
|
|
- Timothy Parker
- 5 years ago
- Views:
Transcription
1 1QFY19 Result Update Institutional Equities South Indian Bank 23 July 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Performance Troughs, Pessimism Peaks South Indian Bank (SBL) reported 1QFY19 results with the key strategic takeaways being: (1) SBL applied the concept of inherent weakness conservatively leading to total slippages of Rs 6.06bn but management has guided for Rs 6-7bn slippages over the remainder of FY19 (2) Core fee income growth was tepid due to the absence of PSLC income (~Rs 200mn in 1QFY18) (3) Hit from (a) gratuity revision (Rs 204.5mn) and (b) MTM loss (Rs 343mn) that remained unamortized as of 4QFY18 were, conservatively, fully absorbed (4) NIM contracted ~10 bps QoQ and ~20 bps YoY to 2.6% but management guided for NIM reversion to 2.8% in ~6 months on the back of MCLR resets. (See comprehensive conference call takeaways on page 2; see initiating coverage report here). Per se, on the results front, SIBL posted NII growth of 7.3% YoY at Rs4,943mn, PPOP decline of 28.9% YoY at Rs2,696mn and PAT decline of 77.3% YoY at Rs230mn. We have revised our estimates for FY19/FY20 and have retained Buy rating on SBL, revising our target price to Rs26 (from Rs30 earlier) and valuing the stock at 0.75x FY20E P/BV. SBL applied the concept of inherent weakness conservatively leading to total slippages of Rs 6.06bn: One social infra account (Rs 1.05bn), two cashew sector accounts (Rs 1.17bn) and an EPC account (Rs 0.22bn) slipped upon conservative application of the concept of inherent weakness. As things stand, there is no account standard at SBL that is NPA at another bank. There were no slippages from large syndicated / consortium corporate accounts. However, total corporate slippages were Rs 3.08bn mainly from smaller non-consortium accounts. Slippages from SME segment spiked to Rs 2.26bn and were the primary negative surprise. Of these, ~Rs 1bn were from accounts that had previously been accorded RBI 180-day dispensation for MSMEs. None of the sub-investment grade corporate accounts (18.3% of corporate book on internal rating) are in default. Management guided for total slippages of Rs 6-7bn over the remainder of FY19 and credit costs of ~100 bps for the full year FY19. Core fee income growth was tepid due to the absence of PSLC income: Core fee income grew 8.3% YoY to Rs 910mn. Last year, about Rs 800bn of PSLC fee income was garnered, of which about a fourth was booked in 1QFY18. This was absent in 1QFY19. Business development officers have now been deployed effectively at branches and will start to perform with some lag on the liabilities and cross-sell front. Some incipient signs of improved performance is visible with SA growth of ~6% QoQ. Accelerated amortization of gratuity and MTM hit further compressed bottomline, NIM compression is transient: While SBL had availed respective RBI dispensations for spreading gratuity revision and MTM hits in 4QFY18, they, conservatively, chose to fully absorb the unamortized quantums of Rs 204.5mn and Rs 343 mn during the quarter. MCLR resets over the next ~6 months will aid NIM reversion to ~2.8%. Majority of loans are on 1-year MCLR and recent MCLR hike amounts to 25 bps. NIM compression on account of interest reversals was 9 bps. Valuation and outlook: We have revised our NII estimates by -3.2%/-1.1%, PPOP estimates by -6.4%/- 4.9% and PAT estimates by -15.4%/-8.3% for FY19/FY20, respectively. We have retained Buy rating on SBL, revising our target price on it to Rs26 (from Rs30 earlier) and valuing the stock at 0.75x FY20E P/BV. NBIE Values your patronage- Vote for The Team in the Asia Money poll Click Here BUY Sector: Banking CMP: Rs18 Target Price: Rs26 Upside: 41% Shivaji Thapliyal Research Analyst shivaji.thapliyal@nirmalbang.com Key Data Current Shares O/S (mn) 1,809.5 Mkt Cap (Rsbn/US$mn) 33.3/ Wk H / L (Rs) 35/18 Daily Vol. (3M NSE Avg.) 11,030,740 Price Performance (%) 1 M 6 M 1 Yr South Indian Bank (21.5) (43.0) (35.9) Nifty Index Source: Bloomberg Y/E March (Rsmn) 1QFY19 1QFY18 4QFY18 YoY (%) QoQ (%) Interest income 16,539 14,907 15, Interest expenses 11,597 10,300 10, Net interest income 4,943 4,607 4, NIM (%) (20bps) (13 bps) Non-interest income 1,459 2,193 1,787 (33.5) (18.3) Operating income 6,402 6,800 6,709 (5.9) (4.6) Staff costs 2,111 1,670 1, Other operating expenses 1,594 1,336 1, (4.3) Total operating expenses 3,705 3,005 3, Cost-to-income (%) ,369bps 422bps Pre-provision profit 2,696 3,795 3,109 (28.9) (13.3) Provisions 2,315 2,243 1, PBT 381 1,552 1,623 (75.4) (76.5) Tax (71.9) (68.7) -Effective tax rate bps 987bps PAT 230 1,015 1,141 (77.3) (79.8) EPS (Rs) (77.4) (79.8) BV (Rs) Deposits 7,24,880 6,57,910 7,20, Advances 5,54,440 4,64,980 5,45,
2 Comprehensive Conference Call Takeaways Growth drivers in the advances portfolio were mortgages- 66%, MSME- 21%, agri- 14.2% and auto loans- 31% on a YoY basis. NIM compressed this quarter on account of increased deposit rates and interest reversals contributed 9 bps to NIM compression. The management recently hiked MCLR rates by 25 bps this quarter. Resets will take place over 6 months. The management has guided for NIM to improve to ~2.8% in about 6 months. Management has guided for 1% credit cost for the full year. Slippages in this quarter mainly comprised of Rs.3080mn from corporate segment, Rs.2260mn from MSME, retail & others contributed Rs.610mn and agri Rs.110mn. Corporate slippage comprised of one large account of Rs.1050mn, two cashew accounts worth Rs.1170mn and one EPC account of Rs.220mn. The management stated that they applied the principle of inherent weakness of the fundamentals of the business rather than recovery history in order to evaluate accounts for stress recognition. The management stated that the large corporate book has stabilised as such. There were no corporate slippages from large syndicated/ consortium accounts which were a cause of worry in the past due to lower recovery rates. Break-up of slippages from MSME segment was as follows: Rs590mn trading firms, Rs380mn textile, Rs.360mn food processing, Rs.180mn professional services, Rs.170mn engineering, Rs.150mn metal products, Rs.110mn leather products, Rs.100mn contractors and Rs.130mn from other manufacturing industries. The management has now revised its guidance for slippages for the pending 3 quarters cumulatively to Rs mn. The management is expecting recovery to be not less than Rs. 5000mn in FY19 on account of strong recovery initiatives and platform in place. ~Rs.1000mn worth of MSME slippages which took advantage of RBI dispensation in the previous quarter were classified as NPAs this quarter. The outstanding MSME loans still availing such dispensation is ~Rs.500mn. SIB does not maintain a watchlist on MSME loans. The management stated that the credit appraisal mechanism has been centralized in all segments except for gold loans. SIB has created a centralized credit committee based sanctioning system whereas this was earlier under the control of individual regional heads. The management stated that there s no widespread slippage pressure on the MSME segment as such. There has been some GST transitioning pressure on MSMEs. Within Kerala, there have been issues in the cashew and marine segments. The management stated that there has been very selective sanction with respect to Kerala cashew exposure in the last 3 years. SIB is ensuring reasonable prospective stability with the SME segment through credit underwriting, processing and monitoring. The management is confident of stably growing ~20% YoY in this segment. As per SIB s internal rating of corporate borrower profile, ~18% of the total corporate loan book is below BBB grade vis-a-vis ~9% as per external rating. The management stated none of the below BBB accounts are part of outstanding NPAs. The management also stated that none of these sub-investment accounts are in default. Gross SR book stood at Rs.13110mn with an accumulated provision of Rs.2650mn. SIB provided Rs.40mn in this quarter on SR book. Some of these accounts were RBI indentified NCLT accounts. As resolution occurs, more comfort will come on this front. 2 South Indian Bank
3 SIB has classified all accounts associated with DCCO issues as NPAs. The bank experienced reasonable traction on SA front with a QoQ growth of ~6%. The deployment of business development officers is relatively recent and the full impact of the same will be felt with a lag. The bank s loan book exposure to NCLT Lists 1 and 2 are to 2 accounts worth Rs.3360mn. Provisions on this exposure is ~50%. The management stated that the share of NPAs in MSME is broadly in line with geographical branch distribution. About 45% of the total MSME slippages were from Kerala in this quarter. SIB s focus on adequate security aims to have collateral comprising of immovable assets such as land, building etc beyond primary security such as receivables etc. The management stated that the board has not arrived at a decision on the capital raising front. They also stated that they still have some room to raise Tier 2 capital. The management stated that the LGD on slipped assets will not be high, particularly for MSME business, given that SIB has minimal unsecured business and strong collateral. The management stated that there is no account which is classified as NPA in other banks, is performing with SIB. SIB checks CRILC data to know if accounts are stressed at other banks. GNPA reductions comprised Rs.130mn of cash recoveries and Rs.240mn of upgrades. There were no write-offs during the quarter. Exhibit 1: Financial summary Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Net interest income 15,097 16,754 19,655 24,673 31,985 Pre-provision profit 8,794 12,146 14,808 16,113 21,192 PAT 3,333 3,925 3,349 4,714 7,611 EPS (Rs) ABV (Rs) P/E (x) P/ABV (x) GNPAs (%) NNPAs (%) RoA (%) RoE (%) Exhibit 2: Actual performance versus our estimates (Rsmn) 1QFY19 1QFY18 4QFY18 YoY (%) QoQ (%) 1QFY19E Devi. (%) Net interest income 4,943 4,607 4, ,796 (15) Pre-provision profit 2,696 3,795 3,109 (29) (13) 3,917 (31) PAT 230 1,015 1,141 (77) (80) 267 (14) Exhibit 3: Change in our estimates Revised estimate Earlier estimate % Revision FY19E FY20E FY19E FY20E FY19E FY20E Net interest income (Rsmn) 24,673 31,985 25,479 32,332 (3.2) (1.1) NIM (%) (6bps) 5bps Operating profit (Rsmn) 16,113 21,192 17,220 22,290 (6.4) (4.9) Profit after tax (Rsmn) 4,714 7,611 5,570 8,302 (15.4) (8.3) 3 South Indian Bank
4 Jul-13 Dec-13 May-14 Oct-14 Mar-15 Aug-15 Jan-16 Institutional Equities Jun-16 Nov-16 Apr-17 Sep-17 Feb-18 Jul-18 Exhibit 4: One-year forward P/BV (x) P/BVPS Mean +1 SD -1 SD +2 SD -2 SD 4 South Indian Bank
5 Financials Exhibit 5: Income statement Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Interest income 55,572 58,471 61,928 74,972 92,369 Interest expenses 40,475 41,716 42,273 50,300 60,383 Net interest income 15,097 16,754 19,655 24,673 31,985 Fee income Other Income 4,656 6,606 7,816 6,107 7,345 Net revenues 20,272 23,910 28,028 31,500 40,276 Operating expenses 11,478 11,764 13,220 15,387 19,083 -Employee expenses 6,923 6,765 7,132 8,185 9,635 -Other expenses 4,556 4,999 6,088 7,202 9,448 Pre-provision profit 8,794 12,146 14,808 16,113 21,192 Provisions 3,696 6,144 9,809 8,970 9,661 -Loan loss provision 3,911 6,201 7,008 7,836 8,643 -Provision for investment ,090 1,134 1,018 -Other provisions PBT 5,097 6,002 4,999 7,143 11,532 Tax 1,764 2,077 1,650 2,429 3,921 PAT 3,333 3,925 3,349 4,714 7,611 Exhibit 7: Balance sheet Y/E March (Rsmn) FY16 FY17 FY18 FY19E FY20E Equity Capital 1,350 1,803 1,809 1,899 1,899 Reserves & Surplus 37,106 46,682 50,623 57,141 63,843 Shareholder's Funds 38,456 48,485 52,432 59,040 65,742 Deposits 5,57,207 6,61,175 7,20,296 8,51,247 10,24,102 -Current deposits 19,831 27,526 30,576 37,455 49,157 -Saving deposits 1,04,758 1,29,938 1,40,841 1,74,506 2,30,423 -Term deposit 4,32,618 5,03,712 5,48,879 6,39,286 7,44,522 Borrowings 26,150 19,578 40,434 58,567 71,042 Other liabilities 12,936 13,884 13,697 30,875 50,167 Total liabilities 6,34,749 7,43,122 8,26,859 9,99,729 12,11,053 Cash/Equivalent 32,745 38,877 42,210 55,654 67,898 Advances 4,10,857 4,63,895 5,45,629 6,54,755 7,98,801 Investments 1,47,439 1,94,297 1,83,631 2,23,535 2,66,160 Fixed Assets 4,870 6,561 6,808 7,489 8,237 Other assets 38,837 39,492 48,581 58,297 69,956 Total assets 6,34,749 7,43,122 8,26,859 9,99,729 12,11,053 Exhibit 6: Key ratios Y/E March FY16 FY17 FY18 FY19E FY20E Growth (%) NII growth Pre-provision profit growth (0.4) PAT growth (14.7) Business (%) Deposit growth Advance growth Business growth CD CASA Operating efficiency (%) Cost-to-income Cost-to-assets Productivity (Rsmn) Business per branch 1, , , , ,994.4 Business per employee Profit per branch Profit per employee Spreads (%) Yield on advances Yield on investments Cost of deposits Yield on assets Cost of funds NIMs Capital adequacy (%) Tier I Tier II Total CAR Asset quality (%) Gross NPAs Net NPAs Specific provision coverage Slippage Credit cost Return (%) RoE RoA RoRWA Per share EPS BV ABV Valuation (x) P/E P/BV P/ABV South Indian Bank
6 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 2018 Buy May 2018 Buy July 2018 Buy Rating track graph Not Covered Covered 6 South Indian Bank
7 DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 2014 having Registration no. INH NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: I, Shivaji Thapliyal, the research analyst is the author of this report, hereby certifies that the views expressed in this research report accurately reflects my personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 7 South Indian Bank
8 Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com , Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com /8101, Michael Pillai Dealing Desk michael.pillai@nirmalbang.com /8103, Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai Board No. : /1; Fax. : South Indian Bank
South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018
4QFY18 Result Update Institutional Equities South Indian Bank 15 May 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Asset Quality Pain To Ease Hereafter South Indian Bank (SBL) reported 4QFY18 results with the
More informationPunjab National Bank
4QFY18 Result Update Institutional Equities Punjab National Bank 16 May 2018 Reuters: PNB.BO; Bloomberg: PNB IN Prompt Corrective Action Looms Punjab National Bank (PNB) reported its 4QFY18 results with
More informationPunjab National Bank
Company Update Punjab National Bank 19 September 2018 Reuters: PNB.BO; Bloomberg: PNB IN Concerns Remain; Assign Accumulate We take Punjab National Bank (PNB) out from Under Review and assign an Accumulate
More informationKarnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN
4QFY18 Result Update Institutional Equities Karnataka Bank 17 May 2018 Reuters: KBNK.NS; Bloomberg: KBL IN Plucky Bank And Low Hanging Fruit Karnataka Bank (KBL) reported 4QFY18 results with the key strategic
More information9,500 7,914 8, NIM
3QFY18 Result Update Institutional Equities Federal Bank 16 January 2018 Reuters: FED.BO; Bloomberg: FB IN Quarter Typifies Balanced Growth Engine Federal Bank (FBL) reported 3QFY18 results with the key
More informationInstitutional Equities
4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account
More informationGillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance
2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings
More information2,09,057 1,85,859 2,17, (4.1) NIM
2QFY19 Result Update Institutional Equities State Bank of India 6 November 2018 Reuters: SBI.BO; Bloomberg: SBIN IN Domestic Credit Growth Improves Materially State Bank of India (SBI) reported its 2QFY19
More informationGillette India. Institutional Equities. 1QFY18 Result Update
1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance
More informationJamna Auto Industries
2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were
More informationNESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY
Event Update Institutional Equities NESCO 27 August 2018 Reuters: NSEN.NS; Bloomberg: NSE IN Revenues From Bombay Exhibition Centre May Take A Hit This event update relates to an application made on 14
More informationIndian Oil Corporation
3QFY18 Result Update Institutional Equities Indian Oil Corporation 1 February 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Earnings Outperformance On Account Of Inventory Gains Indian Oil Corporation (IOCL)
More informationColgate-Palmolive (India)
Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue
More informationMuthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.
3QFY18 Result Update Institutional Equities Muthoot Finance 12 February 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Funding Cost Decline Combines With Operating Leverage Muthoot Finance (MFL) reported its
More information18,948 15,784 18, NIM
3QFY18 Result Update IndusInd Bank 12 January 2018 Reuters: INBK.BO; Bloomberg: IIB IN Alive to all Opportunities IndusInd Bank (IBL) reported its 3QFY18 results with the key strategic takeaways being
More informationOperating expenses tracked lower than core total income growth as ABL displayed continued
1QFY19 Result Update Axis Bank 31 July 2018 Reuters: AXSB.BO; Bloomberg: AXSB IN Sub-investment Grade Book Portends Lower Credit Costs Axis Bank (ABL) reported 1QFY19 results with the key strategic pointers
More informationSanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY
3QCY18 Result Update Institutional Equities Sanofi India Reuters: SANO.BO; Bloomberg: SANL IN Robust Performance Sanofi India s revenues in 3QCY18 stood at Rs7,438mn which were above our/consensus estimate
More informationManappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018
3QFY18 Result Update Institutional Equities Manappuram Finance 9 February 2018 Reuters: MNFL.BO; Bloomberg: MGFL IN The Glitter Is Back In Gold Loans Manappuram Finance (MFL) reported its 3QFY18 results
More informationPNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018
4QFY18 Result Update Institutional Equities PNB Housing Finance 4 May 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Continued Display of Embedded Scalability PNB Housing Finance (PNBHF) reported 4QFY18
More informationDalmia Bharat Enterprises
Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported
More informationPower Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution
2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of
More information93,707 77,814 90, NIM
1QFY18 Result Update Institutional Equities HDFC Bank Reuters: HDBK.BO; Bloomberg: HDFCB IN Higher Fee Income Offsets Higher Provisioning HDFC Bank s net interest income or NII grew 20% in 1QFY18 driven
More informationITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%
4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,
More informationPunjab National Bank
1QFY16 Result Update Institutional Equities Punjab National Bank 29 July 2015 Reuters: PNB.BO; Bloomberg: PNB IN Some Respite On Asset Quality Front Punjab National Bank (PNB) reported moderate 1QFY16
More informationState Bank of India. Institutional Equities. 3QFY19 Result Update BUY
3QFY19 Result Update State Bank of India 4 February 2019 Reuters: SBI.BO; Bloomberg: SBIN IN Domestic Growth Continues To Accelerate State Bank of India (SBI) reported its 3QFY19 results with the key pointers
More informationEBITDA 5,076 3, , EBITDA
Result Update Ambuja Cements 21 February 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Healthy Volume Growth, Operating Costs Under Control Ambuja Cements (ACEM) reported a good set of numbers for owing to
More informationBharat Financial Inclusion
3QFY18 Result Update Bharat Financial Inclusion Reuters: BHAF.NS; Bloomberg: BHAFIN IN 31 January 2018 Customer Acquisition Accelerates Meaningfully Bharat Financial Inclusion (BFIL) reported its 3QFY18
More information3,746 2,551 3, NIM
4QFY17 Result Update Institutional Equities Capital First 11 May 2017 Reuters: CAPF.BO; Bloomberg: CAFL IN Net Interest Income Up, But Offset By Elevated Credit Costs Although the net interest income or
More informationMuthoot Finance. Institutional Equities. 2QFY18 Result Update BUY
2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)
More informationFederal Bank. Institutional Equities. Management Meet Update
Management Meet Update Institutional Equities Federal Bank 11 June 2018 Reuters: FED.BO; Bloomberg: FB IN Several Good Things in Store We recently met the CEO of Federal Bank (FBL), Mr Shyam Srinivasan
More informationPNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.
2QFY19 Result Update Institutional Equities PNB Housing Finance 6 November 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Relatively Soft Quarter Not Structural In Nature PNB Housing Finance (PNBHF) reported
More informationPunjab National Bank
4QFY15 Result Update Institutional Equities Punjab National Bank 11 May 2015 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Disappointment Continues Punjab National Bank (PNB) posted dismal 4QFY15 performance,
More informationMuthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017
1QFY18 Result Update Institutional Equities Muthoot Finance 10 August 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Continues To Glitter Strong profitability numbers of Muthoot Finance (MFL)
More informationPunjab National Bank
1QFY18 Result Update Institutional Equities Punjab National Bank 3 August 2017 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Continues To Disappoint Punjab National Bank s (PNB) annualised loan slippage
More informationMuthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018
2QFY19 Result Update Institutional Equities Muthoot Finance 10 December 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Weak quarter not structural in any way Muthoot Finance (MFL) reported its 2QFY19 results
More informationBata India. Institutional Equities. 1QFY19 Result Update BUY
1QFY19 Result Update Institutional Equities Bata India 23 July 2018 Reuters: BATA.BO; Bloomberg: BATA IN Strong Margin Improvement To Drive Consensus EPS Upgrade Bata India s (BIL) YoY net sales growth
More information9,251 7,812 8, NIM
4QFY15 Result Update Institutional Equities IndusInd Bank 17 April 2015 Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Robust Performance IndusInd Bank s 4QFY15 profit beat our estimate by 12%. Its bottom-line
More informationMuthoot Finance. Institutional Equities. 1QFY19 Result Update
1QFY19 Result Update Institutional Equities Muthoot Finance 6 September 2018 Reuters: MUTT.BO; Bloomberg: MUTH IN Sequential Gold Loan AUM Growth Accelerates Further Muthoot Finance (MFL) reported its
More informationIndian Oil Corporation
4QFY18 Result Update Institutional Equities Indian Oil Corporation 24 May 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Subdued Earnings Because Of Lower GRM and Higher Expenses Indian Oil Corporation (IOCL)
More information9,807 8,007 9, NIM
1QFY16 Result Update Institutional Equities IndusInd Bank Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Stellar Performance IndusInd Bank s 1QFY16 profit beat our estimate by 4%. Its bottom-line grew
More informationManappuram Finance. Institutional Equities. 3QFY17 Result Update BUY
3QFY17 Result Update Institutional Equities Manappuram Finance 9 February 2017 Reuters: MNFL.BO; Bloomberg: MGFL IN Profitability Beats Expectations Amid Some Spike In Loan Delinquency Strong Profit &
More informationInstitutional Equities
1QFY19 Result Update Institutional Equities Aurobindo Pharma 13 August 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN One-offs Impact Margin Aurobindo Pharma (APL) reported 1QFY19 revenues of Rs42,503mn which
More informationNestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%
1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven
More informationManappuram Finance. Institutional Equities. 2QFY19 Result Update BUY
2QFY19 Result Update Manappuram Finance 9 November 2018 Reuters: MNFL.BO; Bloomberg: MGFL IN Positive All-round Results Should Set The Tone Manappuram Finance (MFL) reported its 2QFY19 results with the
More informationMold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY
Conference Update Institutional Equities Mold-Tek Packaging 20 August 2018 Reuters: MOLT.BO; Bloomberg: MTEP IN Promising Growth Outlook We recently interacted with the management of Mold-Tek Packaging
More informationInstitutional Equities
Economy Update March CPI Inflation/February IIP 15 April 2019 CPI Inflation Inches Up To 2.86%; IIP Growth Plunges To 0.1% Consumer Price Index or CPI inflation in March 2019 stood at 2.86%, slightly above
More informationState Bank of India. Institutional Equities. 1QFY18 Result Update
1QFY18 Result Update Institutional Equities State Bank of India 14 August 2017 Reuters: SBI.BO; Bloomberg: SBIN IN Merger With Associate Banks Accentuates The Pain State Bank of India s (SBI) annualised
More informationThermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL
3QFY18 Result Update Institutional Equities Thermax 8 February 2018 Reuters: THMX.BO; Bloomberg: TMX IN Healthy Execution, But Margins Disappoint Thermax posted healthy execution in 3QFY18 with standalone
More informationDCB Bank. Institutional Equities. 3QFY19 Result Update. Decisive Move Into Higher RoE Trajectory BUY. 17 January 2019
3QFY19 Result Update Institutional Equities DCB Bank 17 January 2019 Reuters: DCBA.NS; Bloomberg: DCBB IN Decisive Move Into Higher RoE Trajectory DCB Bank (DBL) reported 3QFY19 results with the key pointers
More informationEicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN
Management Meet Update Institutional Equities Eicher Motors 17 July 2018 Reuters: EICH.NS; Bloomberg: EIM IN We had a meeting with the management of Eicher Motors (EML) recently. Following are the key
More informationInstitutional Equities
December 2017 Quarter Result Preview Institutional Equities Oil & Gas Sector 8 January 2018 Higher Crude Oil Prices To Result In Inventory Gains We expect 60%/4.4%/3.7%/6.5% QoQ growth in the December
More informationEBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA
1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance
More informationInstitutional Equities
3QFY18 Result Update Institutional Equities Atul Auto 15 February 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Drag Profitability Atul Auto s (AAL) 3QFY18 earnings missed our expectations
More informationMangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY
Result Update Mangalam Cement 16 February 2018 Reuters: MGLC.BO; Bloomberg: MGC IN Higher Operating costs Hurt Performance Mangalam Cement (MGC) reported a weak performance for on account of higher operating
More informationVoltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE
1QFY19 Result Update Voltas 13 August 218 Reuters: VOLT.BO; Bloomberg: VOLT IN EMPS Shines, UCP Proves Its Mettle Again Voltas reported consolidated revenues of Rs21.5bn for 1QFY19, up 11% YoY and 5%/6%
More informationBank of Baroda. Institutional Equities. 4QFY18 Result Update BUY
4QFY18 Result Update Institutional Equities Bank of Baroda Reuters: BOB.BO; Bloomberg: BOB IN Stress Peaks, Underlying Business Transforming; Upgrade To Buy Bank of Baroda (BoB) reported its 4QFY18 results
More informationInstitutional Equities
Economy Update August CPI Inflation/ July IIP 14 September 2018 CPI Inflation Moderates To 3.69% YoY; IIP Growth Slows To 6.6% YoY Consumer Price Index or CPI inflation stood at 3.69% in August 2018, below
More informationAxis Bank. Institutional Equities. 3QFY19 Result Update BUY. Management Says 18% RoE In The Realm Of Possibility. 30 January 2019
3QFY19 Result Update Axis Bank 30 January 2019 Reuters: AXSB.BO; Bloomberg: AXSB IN Management Says 18% RoE In The Realm Of Possibility Axis Bank (ABL) reported 3QFY19 results with the key pointers being:
More informationEBITDA 6,223 6,511 (4.4) 5, EBITDA
Result Update Institutional Equities Ambuja Cements 26 July 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Performance Beats Expectations, Sustainability Is Key Challenge Ambuja Cements (ACEM) reported steady
More informationSwaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE
2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above
More information26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN
2QFY19 Result Update Maruti Suzuki India 26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN Better-than-expected Margins; Retain Buy Maruti Suzuki India (MSIL) s 2QFY19 earnings were 18% above our estimate
More informationInstitutional Equities
1QFY19 Result Update Institutional Equities Dr. Reddy s Laboratories 27 July 2018 Reuters: REDY.BO; Bloomberg: DRRD IN Drug Pipeline In Place, But Regulatory Hurdles Testing Patience Dr. Reddy s Laboratories
More informationPower Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy
2QFY18 Result Update Power Mech Projects 23 November 217 Reuters: POMP.BO; Bloomberg: POWM IN Strong Business Scalability Likely; Retain Buy Power Mech Projects (PMPL) posted 2QFY18 consolidated revenues
More informationInstitutional Equities
Economy Update Institutional Equities May Inflation/April Index of Industrial Production 13 June 2018 CPI Inflation At 4.9%; IIP Growth Also At 4.9% Consumer Price Index or CPI inflation in India stood
More informationInstitutional Equities
2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of
More informationEBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA
Result Update The India Cements 12 November 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Lackluster Performance The India Cements (ICEM) reported a listless operating performance in because of the sustained
More informationDalmia Bharat Enterprises
Result Update Institutional Equities Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 14 August 218 Listless Performance, But Valuation Premium Continues Dalmia Bharat Enterprises (DBEL)
More informationDabur India. Institutional Equities. 1QFY19 Result Update
1QFY19 Result Update Institutional Equities Dabur India 2 August 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Consistency Is Key To The Game Dabur India s (DABUR) operating performance in 1QFY19 was better
More informationSequent Scientific. Institutional Equities. 1QFY19 Result Update BUY
1QFY19 Result Update Sequent Scientific 13 August 2018 Reuters: SEQU.BO; Bloomberg: SEQ IN Regulatory Changes And Adverse Forex Movement Dampens Momentum Sequent Scientific or SSL s revenues at Rs2,369mn
More informationHindustan Unilever. Institutional Equities. 1QFY19 Result Update
1QFY19 Result Update Institutional Equities Hindustan Unilever 17 July 218 Reuters: HLL.BO; Bloomberg: HUVR IN Breakout Growth Hindustan Unilever (HUVR) has delivered strong volume led top-line growth
More informationTVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL
3QFY19 Result Update TVS Motor Company 23 January 2019 Reuters: TVSM.BO; Bloomberg: TVSL IN Better-Than-Expected Margins TVS Motor Company s 3QFY19 performance was above our expectations as it reported
More informationDabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE
4QFY18 Result Update Institutional Equities Dabur India 3 May 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Growth Volatility Is Still Fairly High Dabur India s (DABUR) consolidated top-line performance in
More informationHindustan Unilever. Institutional Equities. 4QFY18 Result Update
4QFY18 Result Update Institutional Equities Hindustan Unilever 15 May 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Reaping Rewards Of Consistency 4QFY18 was the third consecutive quarter wherein Hindustan
More informationCARE Ratings. Institutional Equities. 2QFY18 Result Update BUY
2QFY18 Result Update Institutional Equities CARE Ratings 17 November 217 Reuters: CREI.BO; Bloomberg: CARE IN Mixed Performance CARE Ratings (CARE) reported an increase of 12.3% in revenues for 2QFY18
More informationConsolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE
Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 2904 Recommendation CMP Target Price BUY Rs. 312 Rs. 443 Better times ahead! reported a good set of numbers in
More informationCrisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport
3QCY17 Result Update Institutional Equities Crisil 18 October 2017 Reuters: CRSL.BO; Bloomberg: CRISIL IN Weak SME Rating Revenues & Currency Movement Play Spoilsport Crisil s 3QCY17 performance was below
More informationValuation and Outlook. Growth (%) PAT (Rs cr)
Feb-18 May-18 Aug-18 Nov-18 Feb-19 4 Recommendation Hold CMP Rs. 67 Target Price Rs. 90 Sector Stock Details Banking BSE Code 590003 NSE Code Bloomberg Code KARURVYSYA KVB IN Market Cap (Rs Cr) Rs. 5,355
More informationTimken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy
4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer
More informationACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE
Event Update Institutional Equities ACC 19 December 218 Reuters: ACC.BO; Bloomberg: ACC IN Capacity Expansion To Consolidate Presence In Central India ACC has announced 5.9mt capacity expansion by adding
More informationInstitutional Equities
3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare
More informationThe Ramco Cements. Institutional Equities. Event Update BUY
Event Update The Ramco Cements 21 December 2018 Reuters: TRCE.BO; Bloomberg: TRCL IN Capacity Expansion To Boost Its Presence In Andhra & Telangana The Ramco Cements (TRCL) has announced 3.15mt cement
More informationEBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA
Result Update Institutional Equities The India Cements 28 May 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Fall In Realisation, Higher Operating Costs Hurt Performance The India Cements (ICEM) reported a weak
More informationIFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.
3QFY18 Result Update Institutional Equities IFB Industries Reuters: IFBI.BO; Bloomberg: IFBI IN Healthy Revenues, Strong Gross Margin; Retain Buy IFB Industries (IFB) posted a healthy 17% YoY rise in net
More informationCrompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely
4QFY15 Result Update Crompton Greaves 29 May 2015 Reuters: CROM.BO; Bloomberg: CRG IN Overseas Losses Continue; More Business Exits Likely The 4QFY15 performance of Crompton Greaves (CGL) was below expectation
More informationInstitutional Equities
Management Meet Update Institutional Equities Kaya Reuters: KAYA.NS; Bloomberg: KAYA IN We interacted with the management of Kaya at an investor conference held by us recently. Following are the key takeaways:
More informationInitiating Coverage. Uflex Ltd.
2904 Recommendation CMP Target Price BUY Rs. 283 Rs. 444 Better times ahead! reported a good set of numbers for the year FY18 and for Q4. Sales for the quarter increase by 11.8% YoY to Rs 1809.8 Cr and
More informationDalmia Bharat Enterprises
Result Update Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 22 May 218 Healthy Performance Led By Good Volume Growth Dalmia Bharat Enterprises (DBEL) reported a healthy performance for
More informationFinancial summary. Year
: price: ABV: How does our one year outlook change? We retain our positive outlook on KVB, led by an improving margin profile and cost containment kicking in, while our key thesis - a proven sole banking
More informationBajaj Electricals. Institutional Equities. 3QFY15 Result Update
3QFY15 Result Update Institutional Equities Bajaj Electricals 13 February 2015 Reuters: BJEL.BO; Bloomberg: BJE IN Final Phase Of Transition Pain; Retain Buy Bajaj Electricals (BJE) posted 3QFY15 revenue
More informationInstitutional Equities
10 April 2019 4QFY19 Result Preview Gains Versus El Nino Headwind Holds The Key; Retain Buy We remain positive on and retain our Buy call on it based on 24% upside to our blended target price of Rs1,134
More informationInstitutional Equities
Company Update Institutional Equities Dr. Reddy s Laboratories 5 September 2017 Reuters: REDY.BO; Bloomberg: DRRD IN Suboxone Generic Opportunity To Be Lucrative, Can Sustain For Longer Time The district
More informationE&P To Stay Strong; Consumer Segment To Revive
Management Meet Update Institutional Equities Bajaj Electricals 30 August 2017 Reuters: BJEL.BO; Bloomberg: BJE IN E&P To Stay Strong; Consumer Segment To Revive We had a meeting with the management of
More informationInstitutional Equities
Event Update Institutional Equities Aurobindo Pharma 10 September 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN Acquires Dermatology and Oral Solids Businesses Of Sandoz Aurobindo Pharma s (APL) acquisition
More informationEBITDA 5,019 4,211 5, EBITDA
Result Update Institutional Equities Dalmia Bharat Reuters: DALA.BO; Bloomberg: DBEL IN Outperformance Likely To Continue Dalmia Bharat (DBL) reported a good set of numbers for, given the challenging environment
More informationLa Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536
4QFY17 Result Update La Opala RG 11 May 217 Reuters: LAOP.BO; Bloomberg: LOG IN Revenues Soar, But Margins Take A Hit La Opala RG (LORL) reported revenues of Rs761mn for 4QFY17, up 41% YoY. The stellar
More informationAtul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017
Management Meet Update Atul Auto 23 August 2017 Reuters: ATUL.BO; Bloomberg: ATUL IN We had a meeting with the management of Atul Auto (AAL) recently to gauge its performance in the aftermath of a relatively
More informationCadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514
3QFY15 Result Update Institutional Equities Cadila Healthcare 11 February 2015 Reuters: CADI.BO; Bloomberg: CDH IN Stable Performance Cadila Healthcare s (CHL) 3QFY15 earnings were in line with our expectations
More informationFederal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector
1QFY218 Result Update Banking August 2, 217 Federal Bank Performance Highlights Particulars (` cr) 1QFY18 4QFY17 % chg (qoq) 1QFY17 % chg (yoy) NII 8.7 842.4 (5.) 692.7 15.6 Pre-prov. profit 557.9 549.2
More informationBata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%
Management Meet Update Bata India Reuters: BATA.BO; Bloomberg: BATA IN On Right Track We had a meeting recently with Mr. R. K. Gupta, Chief Financial Officer (CFO) of Bata India (BIL) to understand recent
More informationLa Opala RG. Institutional Equities. 1QFY18 Result Update
1QFY18 Result Update La Opala RG 31 August 2017 Reuters: LAOP.BO; Bloomberg: LOG IN Flattish YoY Performance La Opala RG (LORL) reported revenues of Rs475mn for 1QFY18, up 0.6% YoY, but significantly below
More information